Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-08-09

FDA Approved: LESSINA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for LESSINA (levonorgestrel and ethinyl estradiol) from Teva Pharmaceuticals USA, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LESSINA (LEVONORGESTREL AND ETHINYL ESTRADIOL)

Snippet

SUPPL AP for LESSINA (LEVONORGESTREL AND ETHINYL ESTRADIOL)